Last $36.47 USD
Change Today +0.10 / 0.27%
Volume 50.4K
CMN On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

cantel medical corp (CMN) Key Developments

Cantel Medical Corp. Declares Regular Semiannual Cash Dividend, Payable on July 31, 2014

CANTEL MEDICAL CORP. announced that its board of directors authorized a regular semiannual cash dividend of $0.045 per outstanding share of the company's common stock. The dividend is payable on July 31, 2014 to shareholders of record at the close of business on July 17, 2014.

Cantel Medical Corp. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended April 30, 2014

Cantel Medical Corp. announced unaudited consolidated earnings results for the third quarter and nine months ended April 30, 2014. For the quarter, the company reported net sales of $120,058,000 compared to $105,009,000 a year ago. Income before interest and income taxes was $16,826,000 compared to $14,223,000 a year ago. Income before income taxes was $16,291,000 compared to $13,490,000 a year ago. Net income was $10,249,000 compared to $8,998,000 a year ago. Diluted earnings per common share were $0.25 compared to $0.22 a year ago. EBITDA was $21,574,000 compared to $18,611,000 a year ago. EBITDAS was $22,996,000 compared to $19,530,000 a year ago. Net debt was $40 million at April 30, which is a reduction of almost $21 million since the end of the last fiscal year. Cash flow EBITDAS was $23 million in the third quarter, which is 17.7% higher than the prior year's third quarter. Cash flow provided by operations was $19.2 million in the third quarter, and finally, capital expenditures was $3.5 million in the third quarter. For nine months, the company reported net sales of $357,372,000 compared to $311,053,000 a year ago. Income before interest and income taxes was $53,347,000 compared to $47,058,000 a year ago. Income before income taxes was $51,538,000 compared to $44,917,000 a year ago. Net income was $32,560,000 compared to $29,026,000 a year ago. Diluted earnings per common share were $0.79 compared to $0.71 a year ago. EBITDA was $67,603,000 compared to $60,000,000 a year ago. EBITDAS was $71,581,000 compared to $62,806,000 a year ago. For the nine-month period, EBITDAS is $71.6 million, which is 14% higher than last year.

Cantel Medical Mulls Acquisitions

Cantel Medical Corp. (NYSE:CMN) is looking for acquisition. An unknown speaker stated, “Our third quarter was unfavorably impacted by $0.01 per share through acquisition related items which included acquisition liability fair value adjustments as well as professional fees associated with our acquisition program. Although these types of expenses will continue in the future, as we continue to pursue and close acquisitions, we highlight these costs since they are not related to our core sales or operating income growth.”

Cantel Medical Corp. to Report Q3, 2014 Results on Jun 05, 2014

Cantel Medical Corp. announced that they will report Q3, 2014 results at 9:00 AM, Eastern Standard Time on Jun 05, 2014

Cantel Medical Corp., Q3 2014 Earnings Call, Jun 05, 2014

Cantel Medical Corp., Q3 2014 Earnings Call, Jun 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CMN:US $36.47 USD +0.10

CMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $39.50 USD +0.36
Hill-Rom Holdings Inc $43.81 USD +0.01
Mesa Laboratories Inc $71.20 USD +0.62
STERIS Corp $56.29 USD +0.49
Transcat Inc $8.79 USD -0.02
View Industry Companies
 

Industry Analysis

CMN

Industry Average

Valuation CMN Industry Range
Price/Earnings 35.3x
Price/Sales 3.2x
Price/Book 4.2x
Price/Cash Flow 35.3x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANTEL MEDICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.